Fetal and neonatal monitoring market was valued at US$ 8,101.1 million in 2020 and is expected to exhibit a CAGR of 6.9% over the forecast period (2021-2028).

The COVID-19 virus 2019 has quickly spread around the world. As the number of illnesses rises, the number of pregnant women and children infected with COVID-19 rises as well. Furthermore, the United States is concentrating on approving non-invasive and remote prenatal and newborn monitoring technologies in order to decrease human-to-human contact and hence coronavirus transmission. The Nuvo Group announced in March 2020 that it has acquired 510 (k) approval from the US Food and Drug Administration to commercialize INVU, a wearable device that monitors fetal and mother heart rates remotely. The gadget is only available with a prescription and should only be used during the third trimester of pregnancy. The patient will wear the INVU sensor band to collect data during remote monitoring periods, which will be scheduled by the healthcare practitioner.

Request Here For Market Latest Insights(PDF): https://www.coherentmarketinsights.com/insight/request-pdf/1319

Due to increased releases of novel products by major players, the global fetal and neonatal monitoring market is anticipated to develop significantly in terms of revenue. The Nuvo-Group, a company dedicated to developing goods and services that use cutting-edge technology in the field of prenatal health and fetal monitoring, was founded in September 2015. Both gadgets are not typical fetal monitoring equipment; instead, they are Bluetooth-connected and may be used with a smartphone app. PregSense is a wearable gadget that allows you to track critical pregnancy statistics in real time. The first device, Sensa, is aimed at home users, while the second, PregSense, is medical-grade and intended for professional usage in fetal screening.

The global fetal and neonatal monitoring market is anticipated to increase due to increasing partnerships and alliances among major players to launch and sell innovative products in various areas. AirStrip, a supplier of mobile healthcare solutions, announced a strategic collaboration with Telenatal in February 2015 to begin delivery of their Sense4Baby wireless fetal/maternal monitor.

In 2013, the fetal monitoring device Sense4Baby obtained 510 (k) approval from the U.S. Food and Drug Administration and a CE certification mark from the European Commission, allowing it to be sold in clinical settings. The creator of Sense4Baby, Sense4Baby Inc., was bought by the business AirStrip in March 2014 in order to market the product globally for improved availability of fetal and neonatal monitoring devices.

Browse 43 Market Data Tables and 23 Figures spread through 184 Pages and in-depth TOC on "Fetal and Neonatal Monitoring Market, by Product Type (Fetal Monitoring Devices (Pulse Oximeters, Uterine Contraction Monitors, Heart Rate Monitors, and Others (Continuous Monitors, Fetal ECG, and Doppler)) and Neonatal Monitoring Devices (Pulse Oximeters, Cardiac Monitors, Blood Pressure Monitors, Capnographs, and Others (MRI, X-ray, and CT Scans))), by Portability (Non-portable Monitoring Devices and Portable Monitoring Devices), by Method (Non-Invasive Monitoring Devices and Invasive Monitoring Devices), by End User (Ambulatory Surgery Centers, Hospitals, Nursing Homes, and Specialty Clinics), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, and Africa) - Global Forecast to 2027"

Several businesses are pursuing acquisitions of other market participants in order to diversify their product portfolios and increase their market position in the global fetal and neonatal monitoring market. Monica Healthcare and its linked fetal monitor technologies were bought by GE Healthcare Life Sciences (a part of General Electric Company) in March 2017. Monica Healthcare is a medical device firm that created the Novii Wireless Patch System, a Bluetooth-connected fetal monitor. It is a one-time-use patch that keeps track of the mother's heart rate, the fetal heart rate, and uterine activity. In 2014, the Novii Wireless Patch System received FDA clearance in the United States. General Electric Company entered the global fetal and neonatal monitoring market with this purchase.

Key Takeaways

Due to rising FDA approvals and new fetal and neonatal monitoring product releases, the global fetal and neonatal monitoring market is anticipated to grow at a CAGR of 6.9 percent over the forecast period (2019-2027).

Purchase this Report - https://www.coherentmarketinsights.com/insight/buy-now/1319

Due to growing clearances in the market, the fetal monitoring devices segment is anticipated to hold a significant revenue share in 2027. The U.S. Food and Drug Administration (FDA) approved MindChild Medical, Inc.'s Pre-Marketing Notification (510(k)) for their MERIDIAN M110 non-invasive fetal cardiac monitor in January 2017. The MERIDIAN M110 intrapartum fetal monitoring equipment monitors and displays FHR (fetal heart rate), MHR (maternal heart rate), and UA (uterine contractions) from the outside.

Fetal and Neonatal Monitoring Market – Competitive Landscape

Key players functioning in the global prosthetic liners market consists of Becton, Dickinson and Company, Fujifilm SonoSite Inc., Medtronic Plc, Dragerwerk AG & Co. KGAA, Cooper Surgical, Getinge AB, Natus Medical Incorporated, GE Healthcare, Siemens Healthcare GmbH, ArjoHuntleigh, Inc., Neoventa Medical, Koninklijke Philips N.V., Analogic Corporation, Spacelabs Healthcare Inc., Smiths Medical, and Masimo.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.